Literature DB >> 8543669

Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival.

V E Valli1, A Norris, R M Jacobs, E Laing, S Withrow, D Macy, J Tomlinson, D McCaw, G K Ogilvie, G Pidgeon.   

Abstract

Biopsy and necropsy specimens, comprising 107 primary carcinomas and three mesenchymal tumours, were reviewed from 110 dogs with cancer of the bladder, urethra, or both. Histological classifications developed for the assessment of human bladder cancer were found to be readily applicable to the dog. These classifications are based on histological features, including the pattern of growth, the cell type, the grade of transitional tumour and the depth of invasion of the bladder wall. Features associated with localized disease in canine transitional cell carcinoma included papillary architecture, "in-situ" tumour, low tumour grade and a strong peritumoral lymphoid cell reaction. Features of tumours with metastasis included infiltrating and non-papillary architecture, increasing tumour grade, depth of invasion, vascular invasion and presence of peritumoral fibrosing reaction. Wide variability was found within single tissue samples, indicating that multiple sample sites are necessary for the adequate characterization of a given lesion. Statistically significant correlations were found between: tumour grade and depth of invasion (P < 0.0001); tumour grade and presence of metastases (P < 0.029); and peritumoral desmoplasia and metastases (P < 0.029). It was concluded that canine bladder cancer could be classified for the purpose of clinical management with a modified World Health Organization system as developed for human tumours.

Entities:  

Mesh:

Year:  1995        PMID: 8543669     DOI: 10.1016/s0021-9975(05)80027-1

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  18 in total

1.  Transitional cell carcinoma of the urinary bladder in a 14-year-old dog.

Authors:  Melissa Caswell
Journal:  Can Vet J       Date:  2011-06       Impact factor: 1.008

2.  Total cysto-prostatectomy: Technique description and results in 2 dogs.

Authors:  Nicholas Bacon; Carlos H de M Souza; Sarah Franz
Journal:  Can Vet J       Date:  2016-02       Impact factor: 1.008

3.  Use of a bipolar sealing device to seal partial cystectomy with and without augmentation with a single-layer simple continuous suture pattern in an ex vivo canine model.

Authors:  Valery F Scharf; Milan Milovancev; Katy L Townsend; Jennifer A Luff
Journal:  Vet Surg       Date:  2020-05-09       Impact factor: 1.495

4.  Laparoscopically implanted tissue expander radiotherapy in canine transitional cell carcinoma.

Authors:  Sean Murphy; Alonso Gutiérrez; Jessica Lawrence; Dale Bjorling; Thomas Mackie; Lisa Forrest
Journal:  Vet Radiol Ultrasound       Date:  2008 Jul-Aug       Impact factor: 1.363

5.  A multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urine.

Authors:  Shay Bracha; Michael McNamara; Ian Hilgart; Milan Milovancev; Jan Medlock; Cheri Goodall; Samanthi Wickramasekara; Claudia S Maier
Journal:  Anal Biochem       Date:  2014-04-02       Impact factor: 3.365

6.  Leiomyosarcoma of urinary bladder in a Shih Tzu dog.

Authors:  Jiyoung Park; Aryung Nam; Hae-Beom Lee; Seong Mok Jeong; Dae-Hyun Kim
Journal:  J Vet Med Sci       Date:  2022-04-15       Impact factor: 1.105

7.  Bacterial urinary tract infections associated with transitional cell carcinoma in dogs.

Authors:  D M Budreckis; B A Byrne; R E Pollard; R B Rebhun; C O Rodriguez; K A Skorupski
Journal:  J Vet Intern Med       Date:  2015-05-01       Impact factor: 3.333

8.  Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.

Authors:  S D Allstadt; C O Rodriguez; B Boostrom; R B Rebhun; K A Skorupski
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

Review 9.  Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.

Authors:  Christopher M Fulkerson; Deepika Dhawan; Timothy L Ratliff; Noah M Hahn; Deborah W Knapp
Journal:  Int J Genomics       Date:  2017-04-09       Impact factor: 2.326

10.  Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq.

Authors:  Shingo Maeda; Hirotaka Tomiyasu; Masaya Tsuboi; Akiko Inoue; Genki Ishihara; Takao Uchikai; James K Chambers; Kazuyuki Uchida; Tomohiro Yonezawa; Naoaki Matsuki
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.